TITLE

TPA

PUB. DATE
January 2005
SOURCE
Taber's Cyclopedic Medical Dictionary;2005, p2211
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the medical term "TPA" is presented. It is used as an acronym for total parenteral alimentation, and tissue plasminogen activator.
ACCESSION #
21248988

 

Related Articles

  • recombinant tPA.  // Taber's Cyclopedic Medical Dictionary;2005, p1860 

    A definition of the term "recombinant tPA" is presented. It refers to the activator for tissue plasminogen.

  • recombinant tPA.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1983 

    A definition of the term "recombinant tPA," which refers to tissue plasminogen activator, is presented.

  • TPA.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2345 

    A definition of the term "TPA," which refers to total parenteral alimentation or tissue plasminogen activator, is presented.

  • TPA. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p753 

    An abbreviation for "tissue-plasminogen activator" is presented.

  • streptokinase.  // Taber's Cyclopedic Medical Dictionary;2005, p2086 

    A definition of the term "streptokinase" is presented. The term refers to an enzyme produced by certain strains of streptococci.

  • TPA via Infusion Catheters Followed by Continuous IV Infusion for 3 Days Prevents Intimal Hyperplasia After Ballon Injury. Kanamasa, Ken; Inoue, Yoshikazu; Otani, Narutaka; Naito, Norikatsu; Morii, Hideki; Ikeda, Akiko; Taniguchi, Mitsugu; Ishida, Norihiro; Hayashi, Takahiro; Ishikawa, Kinji // Angiology;Dec2001, Vol. 52 Issue 12, p819 

    Examines the effects of tissue plasminogen activator (tPA) on the development of intimal hyperplasia. Observation on the intimal cross-sectional areas of the Dispatch catheterized groups; Comparison of intima ratios; Conclusion on the local delivery of tPA.

  • Pharmaceuticals. Greene, Jan; Serb, Chris // H&HN: Hospitals & Health Networks;04/05/97, Vol. 71 Issue 7, p21 

    Presents good news and bad news in a clinical trial of the cardiac drug digoxin. Medical effectiveness of tissue plasminogen activator (TPA); Treatment of stroke patients with TPA; Cost savings of the treatment.

  • Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. de Werf, Frans Van; Arnold, Alfred E.R. // BMJ: British Medical Journal (International Edition);11/26/88, Vol. 297 Issue 6660, p1374 

    Assesses the effect of intravenous recombinant tissue type plasminogen activator on the size of infarct, left ventricular function, and survival in acute myocardial infarction. Rate of ejection fraction after intravenous streptokinase; Limitation of expansion of the infarct and cardiac...

  • In praise of informed scepticism. Godlee, Fiona // BMJ: British Medical Journal;6/22/2013, Vol. 346 Issue 7913, p4 

    An introduction is presented in which the editor discusses various reports within the issue on topics including financial conflicts of interest and physicians, guidelines for use of alteplase, a tissue plasminogen activator and abandoned trials.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics